Showing 2381-2390 of 9965 results for "".
A Promising Pipeline
https://practicaldermatology.com/conferences/maui-derm-2022/a-promising-pipeline/20051/Joel L. Cohen, MD says he's excited about a number of devices he's currently investigating for a wide-variety of medical and aesthetic dermatologic treatments. From body contouring to acne to hair removal, Dr. Cohen shares insights on advancing technologies for several indications.Multidimensional Impact of Prurigo Nodularis
https://practicaldermatology.com/topics/atopic-dermatitis/multidimensional-impact-of-prurigo-nodularis/20048/Like most dermatologists, you may find it challenging to keep up with the rapid discoveries regarding inflammatory skin diseases and new developments in treatment. This informational webinar will provide updates on evolving areas of practice.Optimizing Injectable Results
https://practicaldermatology.com/conferences/asds-2021/optimizing-injectable-results/20021/When it comes to injectables and facial rejuvenation, a panfacial approach can lead to optimal results. But not all patients have the budget for that. Sabrina Fabi, MD shares tips for optimizing results with a low-volume/high-yield treatment plan.DermWireTV: COVID Vaccine Approved; Update on Delta and Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-vaccine-approved-update-on-delta-and-dermatology-practice/19998/FDA approval of Pfizer-BioNTech’s Comirnaty COVID-19 Vaccine comes as Coronavirus case rates surge across the US. We take a look at potential implications for dermatology of the Delta variant spread.Connecting with Industry
https://practicaldermatology.com/series/dermatology-education-foundation/connecting-with-industry/19990/Beyond offering attendees a chance to network with one another, Dermatology Education Foundations meetings are a chance for attendees and industry to interact. Wendy Cantrell, CRNP, DNP says it's great to learn from these knowledgeable representatives, plus an excellent time to tell them how they caA Resurgence: Ablative Resurfacing
https://practicaldermatology.com/conferences/aad-summer-2021/a-resurgence-ablative-resurfacing/19977/Mask mandates, social distancing, and increased tolerance for downtime seem to have led to an uptick in ablative resurfacing. These procedures can offer dramatic results, but Arisa Ortiz, MD says it's important to select the right patients. Plus, she offers tips for post-care counseling to manage paRemoving Obstacles to Dermatologic Care for LGBTQ/GSM Patients
https://practicaldermatology.com/topics/practice-management/removing-obstacles-to-dermatologic-care-for-lgbtqgsm-patients/19935/Members of gender and sexual minority groups may feel less comfortable seeking healthcare than their non-LGBTQ/GSM counterparts. Klint Peebles, MD addresses some of the barriers to access and offers strategies for building more inclusive and welcoming dermatology practices.Assessing the Role of Phototherapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/assessing-the-role-of-phototherapy-in-psoriasis/19887/Despite therapeutic advancements, phototherapy remains a beneficial treatment for many psoriasis patients. Henry Lim, MD summarizes his presentation from San Diego Dermatology Symposium, emphasizing safety and COVID-19 protocols.Microneedling - The essential gateway technology for your growing practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/microneedling-the-essential-gateway-technology-for-your-growing-practice/19809/In this webinar, Lesley Clark-Loeser, MD, FAAD discusses microneedling, its growth in the industry and why every practice should offer the gateway technology. Dr. Clark-Loeser discusses the latest microneedling device introduced into her practice – the Exceed™ medical microneedling device – and thePsoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of p